Last checked at 24 Dec 2020 11:44
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 23 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,048,587 | 2.36% | 684,820 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
365,705 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,414,292 | 2.65% | 1,423,825 | 1.10% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 209.6100 USD |
| Purchase | 2 | 211.9900 USD |
| Purchase | 2 | 209.5350 USD |
| Purchase | 5 | 209.9580 USD |
| Purchase | 6 | 210.1300 USD |
| Purchase | 8 | 209.2100 USD |
| Purchase | 20 | 209.6600 USD |
| Purchase | 39 | 208.9089 USD |
| Purchase | 44 | 209.4900 USD |
| Purchase | 50 | 212.3000 USD |
| Purchase | 55 | 209.6985 USD |
| Purchase | 100 | 208.7900 USD |
| Purchase | 165 | 209.3168 USD |
| Purchase | 200 | 209.7850 USD |
| Purchase | 251 | 210.9574 USD |
| Purchase | 400 | 209.6150 USD |
| Purchase | 470 | 209.2341 USD |
| Purchase | 527 | 211.3208 USD |
| Purchase | 637 | 209.4591 USD |
| Purchase | 775 | 209.1369 USD |
| Purchase | 1,164 | 211.0551 USD |
| Purchase | 1,269 | 210.8091 USD |
| Purchase | 1,342 | 210.7553 USD |
| Purchase | 3,495 | 209.9301 USD |
| Purchase | 5,157 | 209.4899 USD |
| Purchase | 5,235 | 209.5993 USD |
| Purchase | 5,269 | 209.4361 USD |
| Purchase | 5,535 | 210.6089 USD |
| Purchase | 7,289 | 210.9491 USD |
| Purchase | 10,151 | 208.8200 USD |
| Purchase | 13,158 | 210.7635 USD |
| Purchase | 15,353 | 209.4478 USD |
| Purchase | 16,053 | 209.7676 USD |
| Purchase | 20,200 | 209.4170 USD |
| Sale | 2 | 208.9500 USD |
| Sale | 3 | 209.5900 USD |
| Sale | 5 | 209.9580 USD |
| Sale | 10 | 209.6550 USD |
| Sale | 20 | 209.6600 USD |
| Sale | 42 | 208.9554 USD |
| Sale | 97 | 208.3200 USD |
| Sale | 100 | 208.9000 USD |
| Sale | 100 | 208.7900 USD |
| Sale | 206 | 209.1068 USD |
| Sale | 300 | 209.1600 USD |
| Sale | 462 | 209.0646 USD |
| Sale | 470 | 209.2341 USD |
| Sale | 510 | 209.3148 USD |
| Sale | 646 | 208.9426 USD |
| Sale | 775 | 209.1369 USD |
| Sale | 837 | 209.2708 USD |
| Sale | 902 | 209.3988 USD |
| Sale | 1,008 | 209.2228 USD |
| Sale | 1,095 | 208.9581 USD |
| Sale | 1,221 | 209.3460 USD |
| Sale | 1,273 | 209.1211 USD |
| Sale | 1,526 | 209.1944 USD |
| Sale | 3,563 | 210.2920 USD |
| Sale | 4,034 | 209.2981 USD |
| Sale | 4,262 | 209.9946 USD |
| Sale | 4,695 | 209.7585 USD |
| Sale | 5,335 | 209.0673 USD |
| Sale | 7,658 | 208.8200 USD |
| Sale | 11,942 | 209.6129 USD |
| Sale | 12,906 | 209.6402 USD |
| Sale | 14,210 | 209.4885 USD |
| Sale | 33,728 | 210.6664 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 24 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201224005131/en/
Copyright Business Wire 2020